Diagnosis and Management of PAH in Special Populations in the UAE
: Diagnosis and management of pulmonary hypertension (PH) in special populations, including pregnant women, patients requiring intensive care unit admission, and patients who develop complications such as ascites, pericardial effusion or develop COVID-19 infection, are very challenging. : PH is associated with poor outcomes in pregnant women as the haemodynamic changes during pregnancy greatly increase maternal mortality. If PH is suspected in pregnant women, further investigation using transthoracic echocardiography is essential, and confirmation with right heart catheterisation is required. All global guidelines recommend avoidance of pregnancy in patients diagnosed with PAH. However, if the patient becomes pregnant, the risks involved with the continuation of the pregnancy and termination of the pregnancy should be discussed. : Intensive care may be required in patients with PH for the management of comorbid conditions and following major surgeries and irrespective of the underlying cause of PH, haemodynamic compromise in these patients leads to right heart failure. The PH expert centre plays an important role in the critical care management of patients with PH. Patients with PH may also develop complications such as ascites and pericardial effusion; if not rapidly recognised and treated, these complications can lead to poor prognosis in affected patients. : This chapter aims to provide guidance to healthcare professionals in the clinical decision-making process for the diagnosis and management of PH in special populations.
Authors
- Amrish Agrawal (ORCID: https://orcid.org/0000-0003-1863-2455)
- Bassam Mahboub (ORCID: https://orcid.org/0000-0003-4665-6024)
- Marco Harari (ORCID: https://orcid.org/0000-0002-1076-1538)
- Magdi Tofeig (ORCID: https://orcid.org/0000-0001-9782-7247)
- Mohammad Daud Khan (ORCID: https://orcid.org/0000-0001-5076-279X)
- Khaled Saleh (ORCID: https://orcid.org/0000-0003-1161-7076)
- Govinda Bodi (ORCID: https://orcid.org/0000-0001-5114-1688)
- Jihad Mallat (ORCID: https://orcid.org/0000-0001-6372-7360)
- Hazem El Badaoui
- Sharina Aldhaheri
- Aref Al Hakami
- Hani Sabbour (ORCID: https://orcid.org/0000-0001-6960-1056)
- Fady Hamed
- Rizwan Ahmed (ORCID: https://orcid.org/0000-0001-6877-2662)
- Arun Kumar
- Ahmed Reda Taha (ORCID: https://orcid.org/0000-0001-7901-9553)
- Walid Ahmed (ORCID: https://orcid.org/0009-0001-5019-2931)
- Usman Ahmed (ORCID: https://orcid.org/0009-0004-9387-7211)
- Wael Al Mahmeed
- Hosam Zaky
- Ashraf Alzaabi
- Vivek Kakar
- Bashir Salih
- Hussein Heshmat
- Noha Yaseen
- Said Isse (ORCID: https://orcid.org/0009-0006-5891-2768)
- Yogeeswari Vellore Satyanarayanan
- Ramzi Khashkousha
- Mohammed B Al Saiari
- Prof Asim Elnour
- Yasser El Hennawi
- Prof Mohamed Farghaly
Institutions
- Dubai Health Authority (AE)
- Cleveland Clinic (US)
- Cairo University (EG)
- Al Ain University (AE)
- United Arab Emirates University (AE)
- Brown University (US)
- Oasis Hospital (AE)
- Shaikh Khalifa Medical City (AE)
- Dubai Hospital (AE)
- Cleveland Clinic Lerner College of Medicine (US)
- Tawam Hospital (AE)
- Aster (IT)
- Sheikh Shakhbout Medical City (AE)
- Abu Dhabi Health Services (AE)
- Mohammed Bin Rashid University of Medicine and Health Sciences (AE)
- Zayed Military Hospital (AE)
- Corniche Hospital (AE)
- Mediclinic City Hospital (AE)
- Dubai Medical College (AE)
- Case Western Reserve University (US)
- Ras al-Khaimah Medical and Health Sciences University (AE)
Publication Details
- Journal
- New Emirates Medical Journal
- Published
- 2024-12-19
- DOI
- https://doi.org/10.2174/0102506882333704240912062627
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00